Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population

Cost-Effectiveness Analysis of SAPIEN 3 Transcatheter Aortic Valve Implantation Procedure Compared With Surgery in Patients With Severe Aortic Stenosis at Low Risk of Surgical Mortality in France

“…[11][12][13] A recent 10-year cost study using the latestgeneration TAVI devices found notable cost saving with TAVI over SAVR in patients at intermediate risk of surgical mortality. 14 In patients at low risk, TAVI, particularly with balloonexpandable prostheses, was suggested to be a cost-effective option for patients with severe aortic stenosis. 15 Using data from the PARTNER 3 study and cost perspectives based on a French national hospital claim database, the costeffectiveness of TAVI and SAVR in patients with severe aortic stenosis and at low risk of surgical mortality was assessed in this study.…”

The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups

“…The results from the present analysis are consistent with those obtained in the few studies available related to the last generation devices. Indeed, four recent studies evaluated the CE of TAVI versus sAVR in intermediate-risk patients [24,[37][38][39]. Three of them showed TAVI being dominant considering the payer perspective and a lifetime horizon in the US [37], France [24] and Australia [39], while, accounting for the perspective of the National Health System in Canada, Tarride et al [38] found that TAVI was cost-effective (ICER being 28,154 Canadian dollars/QALY).…”

Commentary: It is not yet time for the sunset of aortic valve surgery!

“…It should be noted that SAVR still offers valid results for intermediate-risk patients [4][5][6] both at short and long term, and the TAVI procedural costs are certainly greater than those of SAVR. 7 In this issue of JTCVS, Muneretto and colleagues 8 focused on the clinical effects on intermediate-risk patients who had undergone TAVI compared with SAVR, using sutureless prostheses for the latter. They conducted a multicenter propensity score-matched retrospective study and analyzed the outcomes in two paired groups of 291 patients who had undergone TAVI or SAVR.…”